Group One Trading’s ResMed RMD Stock Holding History

Group One Trading’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$629K	Sell	2,800 -2,800	-50%	-$698K	﹤0.01%	3129
2025 Q4	$1.35M	Buy	5,600 +1,800	+47%	+$460K	﹤0.01%	2622
2025 Q3	$1.04M	Sell	3,800 -300	-7%	-$81.9K	﹤0.01%	2994
2025 Q2	$1.06M	Sell	4,100 -6,000	-59%	-$1.43M	﹤0.01%	2718
2025 Q1	$2.26M	Buy	10,100 +5,900	+140%	+$1.38M	0.01%	1715
2024 Q4	$960K	Buy	4,200 +1,000	+31%	+$241K	﹤0.01%	2611
2024 Q3	$781K	Sell	3,200 -5,600	-64%	-$1.25M	﹤0.01%	2511
2024 Q2	$1.68M	Buy	8,800 +5,300	+151%	+$1.08M	0.01%	1591
2024 Q1	$693K	Buy	3,500 +2,700	+338%	+$495K	﹤0.01%	2427
2023 Q4	$138K	Buy	800 +600	+300%	+$92.2K	﹤0.01%	4201
2023 Q3	$29.6K	Sell	200 -1,600	-89%	-$289K	﹤0.01%	5562
2023 Q2	$393K	Buy	+1,800	New	+$401K	﹤0.01%	3259
2023 Q1	–	Sell	-18,300	Closed	-$3.81M	–	7842
2022 Q4	$3.81M	Buy	18,300 +5,800	+46%	+$1.27M	0.01%	1332
2022 Q3	$2.73M	Buy	12,500 +8,700	+229%	+$1.98M	0.01%	1645
2022 Q2	$797K	Sell	3,800 -8,700	-70%	-$1.85M	﹤0.01%	2964
2022 Q1	$3.03M	Buy	12,500 +5,800	+87%	+$1.4M	﹤0.01%	1981
2021 Q4	$1.75M	Buy	6,700 +4,500	+205%	+$1.17M	﹤0.01%	2755
2021 Q3	$580K	Sell	2,200 -15,600	-88%	-$4.27M	﹤0.01%	4025
2021 Q2	$4.39M	Buy	17,800 +5,000	+39%	+$1.05M	0.01%	1817
2021 Q1	$2.48M	Sell	12,800 -44,700	-78%	-$8.96M	﹤0.01%	2225
2020 Q4	$12.2M	Buy	57,500 +32,900	+134%	+$6.56M	0.02%	694
2020 Q3	$4.22M	Buy	24,600 +24,000	+4,000%	+$4.43M	0.01%	1030
2020 Q2	$115K	Buy	600 +300	+100%	+$49.1K	﹤0.01%	3789
2020 Q1	$44K	Sell	300 -100	-25%	-$15.9K	﹤0.01%	3791
2019 Q4	$62K	Sell	400 -2,400	-86%	-$346K	﹤0.01%	3912
2019 Q3	$378K	Buy	2,800 +2,400	+600%	+$314K	﹤0.01%	2573
2019 Q2	$49K	Sell	400 -300	-43%	-$33.2K	﹤0.01%	3790
2019 Q1	$73K	Sell	700 -4,600	-87%	-$475K	﹤0.01%	3370
2018 Q4	$604K	Buy	5,300 +1,600	+43%	+$171K	0.01%	1876
2018 Q3	$427K	Buy	3,700 +1,800	+95%	+$197K	﹤0.01%	2414
2018 Q2	$197K	Sell	1,900 -8,500	-82%	-$860K	﹤0.01%	3061
2018 Q1	$1.02M	Buy	+10,400	New	+$983K	0.01%	1504
2017 Q4	–	Sell	-9,000	Closed	-$693K	–	5163
2017 Q3	$693K	Buy	+9,000	New	+$688K	0.01%	1824
2017 Q1	–	Sell	-17,500	Closed	-$1.09M	–	4942
2016 Q4	$1.09M	Buy	17,500 +3,700	+27%	+$227K	0.01%	1269
2016 Q3	$894K	Sell	13,800 -24,100	-64%	-$1.6M	0.01%	1352
2016 Q2	$2.4M	Buy	37,900 +6,400	+20%	+$377K	0.03%	716
2016 Q1	$1.82M	Buy	31,500 +5,300	+20%	+$300K	0.03%	825
2015 Q4	$1.41M	Buy	26,200 +25,000	+2,083%	+$1.41M	0.02%	1083
2015 Q3	$61K	Sell	1,200 -5,600	-82%	-$301K	﹤0.01%	3402
2015 Q2	$383K	Sell	6,800 -10,100	-60%	-$637K	0.01%	2005
2015 Q1	$1.21M	Buy	16,900 +7,000	+71%	+$455K	0.02%	931
2014 Q4	$555K	Sell	9,900 -7,900	-44%	-$413K	0.01%	1474
2014 Q3	$877K	Buy	17,800 +14,200	+394%	+$723K	0.01%	1200
2014 Q2	$182K	Sell	3,600 -1,700	-32%	-$84.3K	﹤0.01%	2504
2014 Q1	$237K	Sell	5,300 -1,200	-18%	-$53.9K	﹤0.01%	2300
2013 Q4	$306K	Sell	6,500 -5,100	-44%	-$258K	﹤0.01%	2058
2013 Q3	$613K	Sell	11,600 -4,200	-27%	-$204K	0.01%	1439
2013 Q2	$713K	Buy	+15,800	New	+$750K	0.02%	1067

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading's RMD Position: Q1 2026 in Review

Group One Trading increased its ResMed (RMD) stake by 944% in Q1 2026, buying an estimated $353K and bringing the position to 1,566 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #3661.

Group One Trading first reported a position in RMD in Q4 2013 and has held it in 25 quarters since. The position peaked at $2.49M in Q3 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Group One Trading held 1,566 shares of ResMed worth $352K as of Q1 2026.
Group One Trading bought 1,416 ResMed shares in Q1 2026, an estimated $353K.
ResMed made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3661 holding.
Group One Trading first reported a position in ResMed in Q4 2013 and has held it in 25 quarters since.
Group One Trading's ResMed position peaked at $2.49M in Q3 2020.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.